News & Events
Atomwise and FutuRx Launch A2i Therapeutics – A New Immuno-Oncology Company Funded By Leading Biopharma VCs and the Israeli Innovation AuthorityYahoo Finance, December 18, 2020
FutuRx, together with Ramot at Tel-Aviv University and Glasgow University, Launches Epeius pharma to develop treatments for complex neurological diseasesPRWEB, January 20, 2020
FutuRx Launches GliXogen Therapeutics to Develop Novel Therapies for Multiple Sclerosis and Other Demyelinating DisordersPRWEB, January 14, 2019
The two startups are XoNovo (Alzheimer’s Disease) and Hepy Biosciences (cancer).
New biotech incubator to advance biotechnology products in Israel
FutuRx, a biotechnology incubator in Weizmann Science Park, is pleased to announce that its first two biotechnology companies have started operations. The companies are developing new approaches and candidate drugs in oncology and neurodegenerative disease.